What additional laboratory tests are indicated for a woman with an 11 cm hematoma of unknown cause?

Laboratory Workup for Spontaneous Large Hematoma

For a woman presenting with an 11 cm hematoma without known trauma, immediately order: CBC, PT/INR, aPTT, comprehensive metabolic panel (including liver function tests), and a pregnancy test if of childbearing age. 1

Essential First-Line Testing

The initial laboratory evaluation must focus on identifying coagulopathy, medication effects, and underlying systemic conditions that predispose to spontaneous bleeding:

Mandatory Initial Labs

• Complete blood count (CBC): Assess for thrombocytopenia, anemia from blood loss, and hematologic malignancies 1, 2
• PT/INR and aPTT: Critical to detect warfarin use, coagulation factor deficiencies, and anticoagulant effects. Warfarin-related hemorrhages carry increased morbidity and mortality 1
• Comprehensive metabolic panel: Elevated creatinine associates with hematoma expansion; liver dysfunction suggests coagulopathy 1
• Pregnancy test: Mandatory in women of childbearing age 1

Additional Critical Testing Based on Clinical Context

• Toxicology screen: Essential if patient is young or middle-aged to detect cocaine and sympathomimetic drugs, which are associated with spontaneous hemorrhage 1
• Type and screen: Prepare for potential transfusion given the large hematoma size 3

Second-Line Testing for Bleeding Disorders

If initial coagulation studies are normal but spontaneous hematoma remains unexplained, proceed with von Willebrand disease (VWD) workup as this is the most common inherited bleeding disorder in women. 2

VWD Testing Panel (Grade B Recommendation)

Order all three tests simultaneously 2:

• VWF antigen (VWF:Ag)
• VWF activity (VWF:RCo or newer VWF:GPIbM assay - the latter preferred for better reproducibility)
• Factor VIII coagulant activity

This testing is particularly important because:

• VWD affects up to 1% of the population
• Women with VWD commonly present with mucocutaneous bleeding and hematomas 2, 4
• VWF levels can fluctuate; if levels are <80 IU/dL, repeat testing is warranted 5

Specialized Coagulation Testing

If VWD testing is normal, consider 6, 5, 7:

• Factor XIII activity assay: Critical because FXIII deficiency is NOT detected by PT/aPTT and can cause severe spontaneous bleeding 6, 7, 8
• Individual factor assays (FII, FV, FVII, FX, FXI): Mild deficiencies may not prolong screening tests but can cause clinically significant bleeding 6, 5
• Platelet function testing (light transmission aggregometry): If mucocutaneous bleeding pattern present 6, 5, 7

Clinical Context Matters

Key Historical Red Flags to Elicit

• Medication history: Anticoagulants, antiplatelet agents, NSAIDs, SSRIs, herbal supplements 1
• Personal bleeding history: Prior surgical bleeding, dental extractions, menorrhagia 2
• Family history: Inherited bleeding disorders 2, 9
• Systemic symptoms: Fever, weight loss, night sweats (malignancy), jaundice (liver disease) 1, 2

Physical Examination Priorities

Look specifically for 2:

• Additional ecchymoses, petechiae, or mucosal bleeding
• Hepatosplenomegaly or jaundice (liver disease/coagulopathy)
• Joint hypermobility (Ehlers-Danlos syndrome)
• Telangiectasias (hereditary hemorrhagic telangiectasia)

Common Pitfalls to Avoid

1. Don't assume normal PT/aPTT excludes bleeding disorders: Factor XIII deficiency, mild factor deficiencies, VWD, and platelet disorders can all present with normal screening tests 6, 5, 7

2. Don't order VWF testing only once: VWF is an acute phase reactant and levels fluctuate. If initial levels are 50-80 IU/dL, repeat testing is essential 5

3. Don't forget pregnancy testing: This is non-negotiable in women of childbearing age and can dramatically alter management 1

4. Don't overlook acquired causes: Liver disease, malignancy, and autoimmune conditions (including ANA-negative lupus) can cause acquired coagulopathy 1, 8

Algorithmic Approach

1. Immediate labs: CBC, PT/INR, aPTT, CMP, pregnancy test
2. If coagulation studies abnormal: Correct coagulopathy, investigate cause (warfarin, liver disease, DIC)
3. If coagulation studies normal: Proceed to VWD panel (VWF:Ag, VWF activity, FVIII)
4. If VWD testing normal: Consider Factor XIII assay and individual factor levels
5. If all testing normal but bleeding phenotype convincing: Platelet function testing and hematology consultation

The size of this hematoma (11 cm) without inciting trauma demands thorough investigation beyond basic coagulation screening, as missing an underlying bleeding disorder carries significant implications for future bleeding risk and surgical management.